QTRX - Quanterix - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74766Q1013

Protein Detection Platforms, Immunoassay Instruments, Assays, Reagents

Quanterix Corporation is a life sciences company that focuses on developing and marketing innovative digital immunoassay platforms to advance precision health. These platforms are designed to support life sciences research and diagnostics across various regions, including North America, Europe, the Middle East, Africa, and the Asia Pacific.

The company's product portfolio includes the HD-X instrument, a cutting-edge protein detection platform, and the SR-X instrument, which enables researchers to apply Simoa detection in a broader range of applications. Additionally, Quanterix offers the SP-X instrument, built on Simoa planar array technology, for measuring multiplex chemiluminescent immunoassays.

Quanterix's products also include a comprehensive range of assays, which comprise all necessary components to run enzyme-based immunoassays, such as beads, capture and detector reagents, enzyme reagents, and substrates. Furthermore, the company provides replacement parts, reagents, and antibodies to support researchers and clinicians in their work.

Beyond its product offerings, Quanterix provides contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. These services cater to various fields, including neurology, oncology, cardiology, infectious diseases, and inflammation.

Quanterix primarily targets the life science research sector, selling its products to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies. The company's sales strategy involves a direct field sales approach, supported by organizations and distributors or sales agents.

Founded in 2007 as Digital Genomics, Inc., the company changed its name to Quanterix Corporation in August of the same year. Headquartered in Billerica, Massachusetts, Quanterix continues to drive innovation in the life sciences industry. For more information, visit their website at https://www.quanterix.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for QTRX - Quanterix  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for QTRX - Quanterix  - Stock Price & Dividends

QTRX Stock Overview

Market Cap in USD 484m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2017-12-07

QTRX Stock Ratings

Growth 5y -39.2
Fundamental -54.6
Dividend 0.00
Rel. Performance vs Sector -4.62
Analysts 4.20/5
Fair Price Momentum 12.35 USD
Fair Price DCF -

QTRX Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

QTRX Growth Ratios

Growth 12m -33.33%
Growth Correlation 12m -45%
Growth Correlation 3m -41%
CAGR 5y -13.54%
CAGR/Mean DD 5y -0.26
Sharpe Ratio 12m -0.63
Alpha vs SP500 12m -67.69
Beta vs SP500 5y weekly 1.88
ValueRay RSI 70.16
Volatility GJR Garch 1y 69.57%
Price / SMA 50 3.73%
Price / SMA 200 -25.16%
Current Volume 257.5k
Average Volume 20d 404.8k

External Links for QTRX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of QTRX stocks?
As of July 27, 2024, the stock is trading at USD 15.56 with a total of 257,549 shares traded.
Over the past week, the price has changed by +8.06%, over one month by +26.92%, over three months by +0.00% and over the past year by -37.36%.
What are the forecast for QTRX stock price target?
According to ValueRays Forecast Model, QTRX Quanterix will be worth about 14.6 in July 2025. The stock is currently trading at 15.56. This means that the stock has a potential downside of -6.04%.
Issuer Forecast Upside
Wallstreet Target Price 23.5 51.0
Analysts Target Price 30 92.8
ValueRay Target Price 14.6 -6.04